Changzhou Ruiming Pharmaceutical

Changzhou Ruiming Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Established in 2004, the company operates GMP-compliant facilities and has successfully passed rigorous on-site audits from international regulatory bodies, including the European Union and Japan's PMDA. Its core product portfolio focuses on high-demand small molecule therapeutics for cardiovascular diseases, urology, and metabolic disorders, including well-known compounds like Amlodipine Besylate and Tamsulosin Hydrochloride. The company leverages strong academic partnerships with institutions such as China Pharmaceutical University to advance its chemical synthesis and process optimization capabilities. Ruiming Pharmaceutical primarily serves the global generic pharmaceutical market as a reliable supplier of high-quality raw materials.